These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21951976)

  • 1. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
    Luengo-Fernandez R; Leal J; Gray AM
    Eur J Neurol; 2012 Jan; 19(1):149-54. PubMed ID: 21951976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia.
    Luengo-Fernandez R; Leal J; Gray A
    BMJ Open; 2015 Apr; 5(4):e006648. PubMed ID: 25869683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there underfunding in brain research? The UK research expenditure.
    Winter Y; Oertel WH; Dodel R
    Eur J Neurol; 2012 Jan; 19(1):4-5. PubMed ID: 21914051
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom.
    Sussex J; Feng Y; Mestre-Ferrandiz J; Pistollato M; Hafner M; Burridge P; Grant J
    BMC Med; 2016 Feb; 14():32. PubMed ID: 26908129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studies.
    Landeiro F; Harris C; Groves D; O'Neill S; Jandu KS; Tacconi EMC; Field S; Patel N; Göpfert A; Hagson H; Leal J; Luengo-Fernández R
    Lancet Healthy Longev; 2024 Aug; 5(8):e514-e523. PubMed ID: 39068947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underfunding of stroke research: a Europe-wide problem.
    Pendlebury ST; Rothwell PM; Algra A; Ariesen MJ; Bakac G; Czlonkowska A; Dachenhausen A; Krespi Y; Kõrv J; Krolikowski K; Kulesh S; Michel P; Thomassen L; Bogousslavsky J; Brainin M
    Stroke; 2004 Oct; 35(10):2368-71. PubMed ID: 15308781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
    Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
    BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK investments in global infectious disease research 1997-2010: a case study.
    Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
    Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSFC health research funding and burden of disease in China.
    Xu G; Zhang Z; Lv Q; Li Y; Ye R; Xiong Y; Jiang Y; Liu X
    PLoS One; 2014; 9(11):e111458. PubMed ID: 25369330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding.
    Lowin A; Knapp M; McCrone P
    Int J Geriatr Psychiatry; 2001 Dec; 16(12):1143-8. PubMed ID: 11748773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high cost of not funding stroke research: a comparison with heart disease and cancer.
    Rothwell PM
    Lancet; 2001 May; 357(9268):1612-6. PubMed ID: 11377668
    [No Abstract]   [Full Text] [Related]  

  • 12. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
    Head MG; Brown RJ; Clarke SC
    J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matching taxpayer funding to population health needs.
    Hanna M
    Circ Res; 2015 Apr; 116(8):1296-300. PubMed ID: 25858062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between funding by the National Institutes of Health and the burden of disease.
    Gross CP; Anderson GF; Powe NR
    N Engl J Med; 1999 Jun; 340(24):1881-7. PubMed ID: 10369852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
    Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
    Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
    Carter AJ; Nguyen CN
    BMC Public Health; 2012 Jul; 12():526. PubMed ID: 22800364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of hypertension-related ill-health attributable to environmental noise.
    Harding AH; Frost GA; Tan E; Tsuchiya A; Mason HM
    Noise Health; 2013; 15(67):437-45. PubMed ID: 24231422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between disease burden and research funding through the Health Research Foundation in Spain].
    Gómez-García T; Moreno-Casbas T; González-María E; Fuentelsaz-Gallego C
    Enferm Clin; 2014; 24(4):219-32. PubMed ID: 24819151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values.
    Carter AJ; Delarosa B; Hur H
    Health Res Policy Syst; 2015 Nov; 13():62. PubMed ID: 26526609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.